420 related articles for article (PubMed ID: 32682050)
21. A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease.
Lambrecht J; Verhulst S; Mannaerts I; Sowa JP; Best J; Canbay A; Reynaert H; van Grunsven LA
EBioMedicine; 2019 May; 43():501-512. PubMed ID: 31036530
[TBL] [Abstract][Full Text] [Related]
22. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Arbelaiz A; Azkargorta M; Krawczyk M; Santos-Laso A; Lapitz A; Perugorria MJ; Erice O; Gonzalez E; Jimenez-Agüero R; Lacasta A; Ibarra C; Sanchez-Campos A; Jimeno JP; Lammert F; Milkiewicz P; Marzioni M; Macias RIR; Marin JJG; Patel T; Gores GJ; Martinez I; Elortza F; Falcon-Perez JM; Bujanda L; Banales JM
Hepatology; 2017 Oct; 66(4):1125-1143. PubMed ID: 28555885
[TBL] [Abstract][Full Text] [Related]
23. ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
Seo W; Gao Y; He Y; Sun J; Xu H; Feng D; Park SH; Cho YE; Guillot A; Ren T; Wu R; Wang J; Kim SJ; Hwang S; Liangpunsakul S; Yang Y; Niu J; Gao B
J Hepatol; 2019 Nov; 71(5):1000-1011. PubMed ID: 31279903
[TBL] [Abstract][Full Text] [Related]
24. Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology.
Jansen F; Nickenig G; Werner N
Circ Res; 2017 May; 120(10):1649-1657. PubMed ID: 28495995
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.
Lim HK; Jeffrey GP; Ramm GA; Soekmadji C
Front Cell Infect Microbiol; 2020; 10():587628. PubMed ID: 33240824
[TBL] [Abstract][Full Text] [Related]
26. Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases.
Eguchi A; Feldstein AE
Liver Res; 2018 Mar; 2(1):30-34. PubMed ID: 30345152
[TBL] [Abstract][Full Text] [Related]
27. Extracellular Vesicles as Inflammatory Drivers in NAFLD.
Srinivas AN; Suresh D; Santhekadur PK; Suvarna D; Kumar DP
Front Immunol; 2020; 11():627424. PubMed ID: 33603757
[TBL] [Abstract][Full Text] [Related]
28. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.
Ban LA; Shackel NA; McLennan SV
Int J Mol Sci; 2016 Mar; 17(3):376. PubMed ID: 26985892
[TBL] [Abstract][Full Text] [Related]
29. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
Dorairaj V; Sulaiman SA; Abu N; Abdul Murad NA
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143043
[TBL] [Abstract][Full Text] [Related]
30. HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis.
Bruno S; Pasquino C; Herrera Sanchez MB; Tapparo M; Figliolini F; Grange C; Chiabotto G; Cedrino M; Deregibus MC; Tetta C; Camussi G
Mol Ther; 2020 Feb; 28(2):479-489. PubMed ID: 31757759
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application.
Urban SK; Mocan T; Sänger H; Lukacs-Kornek V; Kornek M
Semin Liver Dis; 2019 Feb; 39(1):70-77. PubMed ID: 30654391
[TBL] [Abstract][Full Text] [Related]
32. Extracellular Vesicles: A Therapeutic Option for Liver Fibrosis.
Bruno S; Chiabotto G; Camussi G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549355
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA.
Tadokoro T; Morishita A; Masaki T
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360904
[TBL] [Abstract][Full Text] [Related]
34. Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools.
D'Anca M; Fenoglio C; Buccellato FR; Visconte C; Galimberti D; Scarpini E
Cells; 2021 Jul; 10(7):. PubMed ID: 34359903
[TBL] [Abstract][Full Text] [Related]
35. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles participate in macrophage-involved immune responses under liver diseases.
Shao J; Li S; Liu Y; Zheng M
Life Sci; 2020 Jan; 240():117094. PubMed ID: 31760101
[TBL] [Abstract][Full Text] [Related]
37. Role of adipocyte-derived extracellular vesicles during the progression of liver inflammation to hepatocellular carcinoma.
Vp V; Kannan A; Perumal MK
J Cell Physiol; 2023 Jun; 238(6):1125-1140. PubMed ID: 36960683
[TBL] [Abstract][Full Text] [Related]
38. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer.
Uzzaman A; Zhang X; Qiao Z; Zhan H; Sohail A; Wahid A; Shang Z; Guan X; Cao CX; Xiao H
Biochimie; 2020 Oct; 177():132-141. PubMed ID: 32835735
[TBL] [Abstract][Full Text] [Related]
39. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases.
Newman LA; Muller K; Rowland A
Cell Mol Life Sci; 2022 Apr; 79(5):232. PubMed ID: 35397694
[TBL] [Abstract][Full Text] [Related]
40. Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human.
Musaddaq G; Shahzad N; Ashraf MA; Arshad MI
Biomarkers; 2019 Mar; 24(2):103-109. PubMed ID: 30252499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
